Conflict of interest
Shinichi, Barrett, honoraria/lecture
BARRETT
Noriko Fukuhara has received research grants from AbbVie, Bayer, Eisai, Gilead Sciences, Ono Pharmaceutical, and Solasia Pharma and honoraria from Chugai and Kyowa Kirin. Dai Maruyama has received research grants from Celgene, Novartis, Chugai, Ono Pharmaceutical, Takeda, Janssen, and MSD and honoraria from Janssen, Mundipharma, Eisai, and Chugai. Kiyohiko Hatake has received honoraria/lecture fees from Takeda, Chugai, Celgene, Otsuka, Towa, Kyowa Kirin, Daiichi Sankyo, Eisai, Yakult Honsha, and Meiji Seika Pharma and consulting fees from Eisai. Hirokazu Nagai has received research grants from AstraZeneca, Celgene, Mundipharma, Zenyaku Kogyo, Takeda, Chugai, Bayer, Bristol Myers Squibb, Janssen, Kyowa Kirin, Ono Pharmaceutical, MSD, and SymBio Pharmaceuticals and honoraria/lecture fees from Eisai, Chugai, Takeda, Celgene, Mundipharma, Kyowa Kirin, Ono Pharmaceutical, AstraZeneca, Sanofi, Bristol Myers Squibb, Novartis, Janssen, SymBio Pharmaceuticals, Chordia Therapeutics, and Nihon Medi-Physics. Shinichi Makita has received honoraria from Celgene, Bristol Myers Squibb, Chugai, CSL Behring, Daiichi Sankyo, Eisai, Novartis, SymBio Pharmaceuticals, and Takeda and advisory board fees from Takeda, Celgene, Bristol Myers Squibb, Daiichi Sankyo, and Novartis. Shigeru Kusumoto has received research grants from Chugai, Daiichi Sankyo, Kyowa Kirin, Janssen, Bristol Myers Squibb, and Bayer and honoraria/lecture fees from Chugai, Daiichi Sankyo, Kyowa Kirin, Janssen, and Bristol Myers Squibb. Junya Kuroda has received research grants from Kyowa Kirin, Chugai, Ono Pharmaceutical, Sanofi, Eisai, Bristol Myers Squibb, Sysmex, Sumitomo Dainippon Pharma, Nippon Shinyaku, AbbVie, Teijin, and Otsuka Pharmaceutical; honoraria from Janssen K.K., Kyowa Kirin, Chugai, Ono Pharmaceutical, Sanofi, Eisai, SymBio, Bristol Myers Squibb, Astellas Pharma, Pfizer, Nippon Shinyaku, Daiichi Sankyo, Sumitomo Dainippon Pharma, AbbVie, Novartis, and Otsuka Pharmaceutical; and consultant fees from Janssen K.K. and Bristol Myers Squibb. Masamitsu Yanada has received research grants from AbbVie, AstraZeneca, Bayer, Celgene, Chugai, Eisai, IQVIA, Genmab, Incyte, Mundipharma, Novartis, Ono Pharmaceutical, Otsuka Pharmaceutical, Solasia Pharma, SymBio, Takeda, Yakult, and Zenyaku Kogyo. Youko Suehiro has received research grants from Chugai, Genmab, Kyowa Kirin, Incyte, Amgen, Ono Pharmaceutical, Otsuka Pharmaceutical, and Teijin and honoraria from Chugai, Ono Pharmaceutical, Takeda, Eisai, Kyowa Kirin, Celgene, Otsuka Pharmaceutical, Sumitomo Dainippon Pharma, Bristol Myers Squibb, AbbVie, Meiji Seika Pharma, Pfizer, and Sanofi. Hironobu Minami has received research grants from Asahi Kasei Pharma, Astellas, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Chugai, CSL Behring, Daiichi Sankyo, Sumitomo Dainippon Pharma, Eisai, Kyowa Kirin, Lilly, Merck Serono, Mitsubishi Tanabe, MSD, Nippon Kayaku, Nippon Shinyaku, Ono Pharmaceutical, Otsuka Pharmaceutical, Sanofi, Shionogi, Takeda, Taiho, Teijin, and Tsumura; honoraria from AbbVie, Bayer, Bristol Myers Squibb, Chugai, Daiichi Sankyo, Sumitomo Dainippon Pharma, Eisai, Genomic Health, Kyowa Kirin, Lilly, Meiji Seika Pharma, Merck Serono, MSD, Nihon Servier, Novartis, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer, Sanofi, Taiho, and Takeda; and grants for clinical trials from AstraZeneca, Bayer, Bristol Myers Squibb, Chugai, Daiichi Sankyo, MSD, Ono Pharmaceutical, Pfizer, Taiho, Amgen, Novartis, and Insight Bioscience Japan. Jose Garcia-Vargas and Barrett H. Childs are employees of Bayer Healthcare Pharmaceuticals Inc. Masanobu Yasuda, Shigeo Masuda, Toshiaki Tsujino, and Yui Terao are employees of Bayer Yakuhin Ltd. Kenjiro Kamezaki, Toshiki Uchida, Chisako Iriyama, and Norifumi Tsukamoto declare no conflict of interest. Kensei Tobinai has received honoraria from Zenyaku Kogyo and HUYA Bioscience.